Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medica SurB de CVMEX:MEDICAB 82 PB Ratio is 2.15 as of Jul. 20, 2026, which is 54% above its 10-year median of 1.40. GuruFocus rates MEX:MEDICAB with a GF Score™ of 82/100 and a GF Value™ of MXN46.74 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Medica SurB de CV ranks worse than 52.8% on this metric.
Medica Sur SAB de CV stock PB Ratio (=2.15) is close to 10-year high of 2.25.
The historical rank and industry rank for Medica SurB de CV's PB Ratio or its related term are showing as below:
MEX:MEDICAB'
s PB Ratio Range Over the Past 10 Years
Min: 0.43 Med: 1.4 Max: 2.25
Current: 2.15
During the past 13 years, Medica SurB de CV's highest PB Ratio was 2.25. The lowest was 0.43. And the median was 1.40.
MEX:MEDICAB's PB Ratio is ranked worse than 52.8% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 2.015
vs MEX:MEDICAB: 2.15
During the past 12 months, Medica SurB de CV's average Book Value Per Share Growth Rate was 12.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -0.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medica SurB de CV was 16.10% per year. The lowest was -18.20% per year. And the median was 7.80% per year.
Back to Basics: PB Ratio
Medica SurB de CV (MEX:MEDICAB) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medica SurB de CV PB Ratio Related Terms
Medica SurB de CV PB Ratio Historical Data
* Premium members only.
The historical data trend for Medica SurB de CV's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medica SurB de CV's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medica SurB de CV PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medica SurB de CV's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medica SurB de CV (MEX:MEDICAB) has a PB Ratio of 2.15 as of Jul. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medica SurB de CV and its competitors. This is 54% above median its historical median of 1.40. Over the past decade, Medica SurB de CV's PB Ratio has ranged from 0.43 to 2.25. According to the industry distribution chart, Medica SurB de CV ranks #321 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 52.8%.
Is Medica SurB de CV's PB Ratio too high?
Medica SurB de CV's current PB Ratio of 2.15 is 54% above median its 10-year median of 1.40. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 2.25. The Healthcare Providers & Services industry median PB Ratio is 2.02. Medica SurB de CV's value of 2.15 is 6.7% above this industry median. Based on the distribution chart, Medica SurB de CV ranks #321 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Medica SurB de CV has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #321 out of 608 companies for PB Ratio. This places Medica SurB de CV in the lower half of its industry. The industry median PB Ratio is 2.02. Medica SurB de CV's value of 2.15 is 6.7% above this benchmark. Historically, Medica SurB de CV's own PB Ratio has ranged from 0.43 to 2.25 over the past decade. While the company's 10-year median is 1.40 vs. the industry median of 2.02, Medica SurB de CV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.02, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medica SurB de CV's current PB Ratio of 2.15 is 6.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medica SurB de CV and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medica SurB de CV's current PB Ratio is 2.15, which is 54% above median its own 10-year median of 1.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Based on GuruFocus' analysis, Medica SurB de CV (MEX:MEDICAB) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN46.74, compared to a current price of MXN59.50 — trading 27.3% above its estimated fair value. The current PB Ratio is 2.15, which is 54% above median its 10-year median of 1.40 and 6.7% above the Healthcare Providers & Services industry median of 2.02. Medica SurB de CV's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medica SurB de CV (MEX:MEDICAB), the current PB Ratio is 2.15 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MEX:MEDICAB) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of MXN59.50 is trading 27.3% above its estimated GF Value™ of MXN46.74.
GuruFocus considers Medica SurB de CV to be Modestly Overvalued.
Key valuation signals for MEX:MEDICAB:
PB Ratio: 2.15 (54% above median its 10-year median of 1.40)
GF Value™: MXN46.74 vs. price of MXN59.50 (27.3% above fair value)
Industry Position: 6.7% above the Healthcare Providers & Services median (#321 of 608)
No single metric tells the full story. See the MEX:MEDICAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
82GF Score
Get the complete analysis for MEX:MEDICAB
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MEDICAB has been successfully added to your 
